Metronidazole
- Product NDC
- 55154-2343
- 11-digit product format
- 551542343
- Labeler code
- 55154
- Product ID
- 55154-2343_5e653564-7189-42a5-b0ec-a189e21d009b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- METRONIDAZOLE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Cardinal Health 107, LLC
- Application
- ANDA205245
- Marketing category
- ANDA
- Marketing start
- 2025-03-05
- Substance
- METRONIDAZOLE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A205245-001 | METRONIDAZOLE | METRONIDAZOLE | 250MG | TABLET / ORAL | AB | 2015-09-23 | |
| A205245-002 | METRONIDAZOLE | METRONIDAZOLE | 500MG | TABLET / ORAL | AB | 2015-09-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A205245-001 | AB |
| A205245-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A205245-001 | METRONIDAZOLE | 250MG | TABLET / ORAL | AB | 2015-09-23 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A205245-002 | METRONIDAZOLE | 500MG | TABLET / ORAL | AB | 2015-09-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A205245-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A205245-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metronidazole | METRONIDAZOLE | Cardinal Health 107, LLC | 4e1ac737-c353-4764-bd35-dc844e75b562 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 205245 ANDA205245 55154-2343 |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | 5cc3fd98-d579-432e-a4b5-b6d5586991a6 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 205245 ANDA205245 |
| Metronidazole | METRONIDAZOLE | Northwind Health Company, LLC | f2f55405-7f21-3ccc-e053-2a95a90a195a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 205245 ANDA205245 |
| Metronidazole | METRONIDAZOLE | Northwind Health Company, LLC | f7e5dacd-0bc4-4ac4-e053-6394a90a457a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 205245 ANDA205245 |
| Metronidazole | METRONIDAZOLE | Chartwell RX, LLC | 40509b3c-b725-400c-abe5-d6d5714d405d | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | 205245 ANDA205245 |
| Metronidazole | METRONIDAZOLE | Major Pharmaceuticals | 71f5ce2f-17f8-45fc-b27d-2bf982591ab3 | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | 205245 ANDA205245 |
| Metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals,Inc. | a860b097-7447-a3b7-e053-2995a90a4bfd | 2024-12-26 | Boxed warning, Warnings, Adverse reactions | 205245 ANDA205245 |
| Metronidazole | METRONIDAZOLE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | d9e33638-3803-426e-a1c3-7d0cf145d92f | 2024-07-22 | Boxed warning, Warnings, Adverse reactions | 205245 ANDA205245 |
| Metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals,Inc. | ae2e4bbe-8c12-4af9-e053-2a95a90af299 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 205245 ANDA205245 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Metronidazole
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| METRONIDAZOLE | 250 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 140QMO216E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 314106 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4e1ac737-c353-4764-bd35-dc844e75b562 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 8ffb9b1d-3ed7-ba2e-677e-47d4d134fd55 | Product name | 5 | 20251024 |
| 7f6d14e0-4366-41bc-a4a9-b74c79a20e17 | Product name | 1 | 20250623 |
| e6d321b0-0e5e-7da6-f043-92b6a91f00a1 | Product name | 5 | 20250515 |
| e1aac33b-94ae-4ee9-905b-299f7263853b | Product name | 3 | 20250124 |
| 16642716-d28a-4f90-8dcb-3921cd8c8109 | Product name | 4 | 20240516 |
| 0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15 | Product name | 1 | 20240313 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| a5070875-62bb-61e1-fd46-8f7054197a40 | Product name | 8 | 20180215 |
| 0add4de9-d152-3375-3390-1123dddc5e3d | Product name | 1 | 20140508 |
| 33ca0fcc-1011-92dc-50a9-a383683eed1e | Product name | 1 | 20140508 |
| 53f39d9f-cd3f-04e1-c668-d4580719d57d | Product name | 1 | 20140508 |
| a804000f-b74f-0b5d-d17b-aa767c286ddb | Product name | 1 | 20140508 |
| a91ea265-6e02-c08f-93c8-686d54180529 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55154-2343-0 | Metronidazole | 1 in 1 BLISTER PACK | TABLET | 1 | 2 | |
| 55154-2343-0 | Metronidazole | 10 in 1 BAG | TABLET | 10 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55154-2343 | METRONIDAZOLE TABLET [CARDINAL HEALTH 107, LLC] | 1 | Current NDC, 2 package rows | 20250309_4e1ac737-c353-4764-bd35-dc844e75b562.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 314106 | metroNIDAZOLE 250 MG Oral Tablet | PSN | 4e1ac737-c353-4764-bd35-dc844e75b562 | 2 |
| 314106 | metronidazole 250 MG Oral Tablet | SCD | 4e1ac737-c353-4764-bd35-dc844e75b562 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 55154-2343-0 | 55154234300 | 10 BLISTER PACK in 1 BAG (55154-2343-0) / 1 TABLET in 1 BLISTER PACK | 10 blister pack | 2025-03-05 | No | No | Current |